Atypical antipsychotic-induced weight gain: insights into mechanisms of action.
about
Detection of metabolic syndrome in schizophrenia and implications for antipsychotic therapy : is there a role for folate?Time-dependent changes and potential mechanisms of glucose-lipid metabolic disorders associated with chronic clozapine or olanzapine treatment in ratsRandomized controlled trial comparing changes in serum prolactin and weight among female patients with first-episode schizophrenia over 12 months of treatment with risperidone or quetiapineAPOA-I: a possible novel biomarker for metabolic side effects in first episode schizophrenia.Novel 4-substituted-N,N-dimethyltetrahydronaphthalen-2-amines: synthesis, affinity, and in silico docking studies at serotonin 5-HT2-type and histamine H1 G protein-coupled receptors.Antipsychotic-induced changes in blood levels of leptin in schizophrenia: a meta-analysis.Effect of Serum Leptin on Weight Gain Induced by Olanzapine in Female Patients with SchizophreniaDopamine D2/3 receptor antagonism reduces activity-based anorexia.Antipsychotic-induced metabolic and cardiovascular side effects in schizophrenia: a novel mechanistic hypothesis.Molecular and behavioral pharmacology of two novel orally-active 5HT2 modulators: potential utility as antipsychotic medications.Associations among obesity, acute weight gain, and response to treatment with olanzapine in adolescent schizophrenia.The role of hypothalamic H1 receptor antagonism in antipsychotic-induced weight gain.The multidimensional nature of metabolic syndrome in schizophrenia: lessons from studies of one-carbon metabolism and DNA methylation.A systematic review of antipsychotic drug effects on human gene expression related to risk factors for cardiovascular disease.Weight gain and antipsychotics: a drug safety review.Treatment of clozapine-associated weight gain: a systematic review.Are medical comorbid conditions of bipolar disorder due to immune dysfunction?Association between history of psychosis and cardiovascular disease in bipolar disorder.Glucagon-like peptide-1 agonists combating clozapine-associated obesity and diabetes.Dopamine antagonists for treatment resistance in autism spectrum disorders: review and focus on BDNF stimulators loxapine and amitriptyline.Antipsychotic-associated weight gain: management strategies and impact on treatment adherence.Exploratory study on association of genetic variation in TBC1D1 with antipsychotic-induced weight gain.Peroxisome proliferator-activated receptor gamma (PPARG) Pro12Ala: lack of association with weight gain in psychiatric inpatients treated with olanzapine or clozapine.Obesity in Women: Insights for the Clinician.Neocortical serotonin2A receptor binding predicts quetiapine associated weight gain in antipsychotic-naive first-episode schizophrenia patients.Investigation of molecular serum profiles associated with predisposition to antipsychotic-induced weight gain.Olanzapine Versus Risperidone in Children and Adolescents with Psychosis: A Meta-Analysis of Randomized Controlled Trials.The Complex Relationship between Antipsychotic-Induced Weight Gain and Therapeutic Benefits: A Systematic Review and Implications for Treatment.Monitoring of Metabolic Adverse Effects Associated With Atypical Antipsychotics Use in an Outpatient Psychiatric Clinic.Understanding antipsychotic-induced weight gain and other metabolic issues
P2860
Q26864342-0B7B1BA0-1BA8-4916-8F1A-6B38E898BD25Q33765864-234EE8E4-AC41-4B05-97AE-91B2F5FCCE73Q33995754-A123F615-4E32-4BDD-8FD6-811319C317DFQ34414069-05547B67-A011-43E6-9E4C-30641ED00649Q35186684-7E9D2DD6-EF45-4C87-9CB2-AF63A22D1BC2Q35566086-FC2DE3AF-4794-4D7E-9499-CF0C63DB8BDFQ35941055-4B26C4DA-A808-4AC0-94C0-D7E3B5B595ADQ36043349-E759DCC1-EF94-4BAD-8E08-EB35D899C027Q36852489-8629C104-439F-41E8-8060-68479B800617Q36966228-24572522-567B-401E-8724-7C5D24071AD2Q37244634-3FD8CC5E-8E29-4061-97D5-A993CDA18993Q38103807-91C44BAD-E097-4A61-90B2-C9D9EEE3584DQ38113237-6B63E792-2C9A-4283-A3DE-7ECCA4E4CA5DQ38194900-62F20819-80E3-4841-834D-97DFA9C12B36Q38268590-E0E708E1-8222-46F0-B9E1-7F94075A0388Q38334922-F4FBB90E-3F7D-4179-94D6-8E8B2F5EE845Q38378743-33463B33-EFC8-4AB3-A4C4-26F2AB3CE7DFQ38524175-BDD28D59-F137-4539-8150-F47881668C6EQ38708352-98CD1458-64BC-443B-88A7-54922F01E932Q38881791-AFEF58C4-82B6-4D2D-B65E-3B0C6BEA0079Q41546064-17B19CC4-2274-4DAE-95FC-00251CBBF43BQ43943107-6875EE6F-CD65-45E4-8979-3B0BFCDA8C6FQ44157498-C73FD98B-E7EA-4102-B595-1ACCA654EED4Q46301919-67992676-136F-4EF2-9555-56ABF64FF810Q47173322-FDCD66A0-055E-43C5-908C-33C6D13615A3Q47213104-4BEF01F9-2E48-4DDE-A05C-247C4A781724Q47642665-7FB8600B-D0EB-482C-B849-99208EB7C160Q49481418-1D8CC16D-10EB-467C-8A4A-8AF4A3F68B94Q50044596-116AFDC1-C10C-43EE-82DA-3DA8E6C27BFAQ58201746-C50B2CA1-1968-46BE-BEA6-39CA960FC0F5
P2860
Atypical antipsychotic-induced weight gain: insights into mechanisms of action.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Atypical antipsychotic-induced weight gain: insights into mechanisms of action.
@en
Atypical antipsychotic-induced weight gain: insights into mechanisms of action.
@nl
type
label
Atypical antipsychotic-induced weight gain: insights into mechanisms of action.
@en
Atypical antipsychotic-induced weight gain: insights into mechanisms of action.
@nl
prefLabel
Atypical antipsychotic-induced weight gain: insights into mechanisms of action.
@en
Atypical antipsychotic-induced weight gain: insights into mechanisms of action.
@nl
P2093
P2860
P1433
P1476
Atypical antipsychotic-induced weight gain: insights into mechanisms of action.
@en
P2093
James E Mitchell
James L Roerig
Kristine J Steffen
P2860
P304
P356
10.2165/11596300-000000000-00000
P577
2011-12-01T00:00:00Z
P6179
1007151794